AstraZeneca R&D Montreal awarded PerkinElmer an expanded contract under which it will use PerkinElmer's High Throughput Screening (HTS) assay technologies and functional HTS assays to test compounds.(Organizational changes: sales/orders of note)(Brief Article)

AstraZeneca R&D Montreal awarded PerkinElmer an expanded contract under which it will use PerkinElmer's High Throughput Screening (HTS) assay technologies and functional FITS assays to test compounds against a defined selection of G protein-coupled receptors (GPCR).


The companies have collaborated for six years.